Protecting The Public From Emerging Infectious Diseases
Funder
National Health and Medical Research Council
Funding Amount
$2,500,000.00
Summary
Emerging infectious diseases and pandemics cause potentially enormous but unpredictable health and socioeconomic impacts. This CRE will develop and integrate new technologies, including fingerprinting the entire gene complement of micro-organisms and new electronic communication platforms, to improve the precision and speed of public health responses. We will develop ethics research-based policy frameworks to enable implementation of these technologies into public health practice and policy.
From Broome To Berrima: Building Australia-wide Research Capacity In Indigenous Offender Health And Health Care Delivery
Funder
National Health and Medical Research Council
Funding Amount
$3,018,575.00
Summary
Australia has the highest Indigenous incarceration rate in the OECD which impacts profoundly on Indigenous communities. Further, offender populations endure a greater health burden compared with the general community. This grant develops much needed capacity in offender health research, building a team of Indigenous researchers, and creating an Australia-wide network for sharing knowledge in this field. Outcomes will include better Indigenous offender health services and improved health and well ....Australia has the highest Indigenous incarceration rate in the OECD which impacts profoundly on Indigenous communities. Further, offender populations endure a greater health burden compared with the general community. This grant develops much needed capacity in offender health research, building a team of Indigenous researchers, and creating an Australia-wide network for sharing knowledge in this field. Outcomes will include better Indigenous offender health services and improved health and wellbeing for this marginalised population.Read moreRead less
The control of epidemics requires cross-sectoral engagement across various fields such as health, government, international law and security, at both national and international levels. The changing global landscape poses an increased threat to biosecurity, calling for cross-sectoral collaborative research and engagement. Integrated Systems for Epidemic Response (ISER) will convene and lead multidisciplinary systems research in epidemic response.
Reducing The Health, Social And Economic Burden Of Injecting Drug Use In Australia
Funder
National Health and Medical Research Council
Funding Amount
$2,606,037.00
Summary
Injecting drug use (IDU) is a disproportionately large source of health and social harm. This CRE unites Australia’s leading scientists in the IDU field – researchers working on blood-borne virus epidemiology and treatment, overdose prevention, justice health and psychiatric health - and experts from key non-government organisations. The CRE will develop new ways to improve the health of injecting drug users, and reduce the health and social burden of IDU to the Australian community.
Centre For Research Excellence In Critical Infectious Diseases
Funder
National Health and Medical Research Council
Funding Amount
$2,623,406.00
Summary
Severe infection kills millions of people every year, but clinicians and policy makers rarely get the information they need in time to make potentially life-saving decisions about infection. We will apply modern genomics and information systems to better understand infection threats in critical care environments and explore the ethical and medicolegal aspects that may either facilitate or present barriers to important research and time-critical decision making.
Immunisation In Under Studied And Special Risk Populations: Closing The Gap In Knowledge Through A Multidisciplinary Approach
Funder
National Health and Medical Research Council
Funding Amount
$2,499,969.00
Summary
Much of the vaccine research which informs national policy is conducted by the pharmaceutical industry or by government. However, there are critical research gaps in special-risk and under-served populations where targeted research is not commercially viable. These include research in the extremes of age, Indigenous Australians, migrants, refugees, immunosuppressed and traveller populations. This CRE will address research gaps in such populations, which have not been addressed elsewhere, using n ....Much of the vaccine research which informs national policy is conducted by the pharmaceutical industry or by government. However, there are critical research gaps in special-risk and under-served populations where targeted research is not commercially viable. These include research in the extremes of age, Indigenous Australians, migrants, refugees, immunosuppressed and traveller populations. This CRE will address research gaps in such populations, which have not been addressed elsewhere, using novel, multidisciplinary methods.Read moreRead less